Dechra Pharmaceuticals PLC (DPHAY) is dedicated to the development, manufacturing, regulatory approval, marketing, and sale of veterinary medications and related goods specifically for animal health professionals. The company's operations are structured into three key divisions: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceutical Research and Development. Its extensive product portfolio addresses various animal species: For companion animals like dogs and cats, Dechra offers treatments covering endocrine disorders, dermatological conditions, pain relief, anesthesia, cardiovascular health, and critical care.